Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
They will want to get the price much higher than 4.5p pre placing. Promised good news in Dec and Jan should do the trick.
Best quote at the end...'I have really got the commercialisation traction going'
The contrast between Mr Cheek and David Budd is very stark - we now have a CEO with a plan. contacts, a commercialisation strategy etc etc. He was very tactful in describing the mess he inherited but in less than three months seems to have set a strong direction for the company to achieve rapid commercialisation success. There is now a real hope for both short and medium term positive news flow - I'm very much reassured we have a CEX who knows how to make this company a success and I am sure his approach will also give huge confidence to future investors too. Impressive.
But this is not a negative RNS!
How do you reach that view?!?
A good sign that RF have confidence in the new leadership.
Do you know that's his salary?
I still believe that the CEO would not have taken the job if he didn't think the company had a great future, albeit with speed bumps along the way!
This is old news. See the RNS on 28th Sept. The company has rehighlighted this today to try and cover up the disappointing NICE news re a further delay.
Whether the company is involved or not they can't announce anything until the contracts have been signed for the TRANSFORM programme which is not until next Spring.
I wonder if the company is involved in this ?
https://www.dailymail.co.uk/news/article-12764013/Health-leaders-approve-prostate-cancer-screening-trial.html
Nope sells
Stocksaint....what's the pont of your post? What value does it add to this discussion board. No one cares about your continued trashing of the company.
This is the link to the Innovate UK Transparency data
https://www.ukri.org/publications/innovate-uk-funded-projects-since-2004/
If you go into the excel spreadsheet and search for genedrive you will find details of all the Devote projects and the grant of 188k to Genedrive (line 4762 on the spreadsheet).
Key is as Mr Cheek says, its avoid direct costs and gives them access to patients .
GDR will receive c 200k direct - the rest is to UoM.
Let's hope we receive some positive news soon from todays NICE stroke review committee meeting.I
Roger65...if they are thinking of a placing, won't they want to spike the SP beforehand?
This is the link to the Innovate UK Transparency data
https://www.ukri.org/publications/innovate-uk-funded-projects-since-2004/
If you go into the excel spreadsheet and search for genedrive you will find details of all the Devote projects and the grant of 188k to Genedrive (line 4762 on the spreadsheet).